Cargando…
Upregulation of GPR109A in Parkinson’s Disease
BACKGROUND: Anecdotal animal and human studies have implicated the symptomatic and neuroprotective roles of niacin in Parkinson’s disease (PD). Niacin has a high affinity for GPR109A, an anti-inflammatory receptor. Niacin is also thought to be involved in the regulation of circadian rhythm. Here we...
Autores principales: | Wakade, Chandramohan, Chong, Raymond, Bradley, Eric, Thomas, Bobby, Morgan, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4201464/ https://www.ncbi.nlm.nih.gov/pubmed/25329911 http://dx.doi.org/10.1371/journal.pone.0109818 |
Ejemplares similares
-
Low-dose niacin supplementation modulates GPR109A, niacin index and ameliorates Parkinson’s disease symptoms without side effects
por: Wakade, Chandramohan, et al.
Publicado: (2015) -
Niacin Ameliorates Neuro-Inflammation in Parkinson’s Disease via GPR109A
por: Giri, Banabihari, et al.
Publicado: (2019) -
The dimensionality of fatigue in Parkinson’s disease
por: Chong, Raymond, et al.
Publicado: (2018) -
Niacin Enhancement for Parkinson’s Disease: An Effectiveness Trial
por: Chong, Raymond, et al.
Publicado: (2021) -
Low-Dose Niacin Supplementation Improves Motor Function in US Veterans with Parkinson’s Disease: A Single-Center, Randomized, Placebo-Controlled Trial
por: Wakade, Chandramohan, et al.
Publicado: (2021)